|
|||
|
Multiple Sclerosis Information
Search
This Month
Favorite Links
Month Archive
|
Friday, April 10
by
All About MS
on Fri 10 Apr 2009 03:00 AM CST
Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) today announced five-times as many multiple sclerosis (MS) patients taking TYSABRI® (natalizumab) were free from disease activity versus placebo in the overall patient population. Results more »
by
All About MS
on Fri 10 Apr 2009 12:00 AM CST
During the 1990s, the American-led project to discover and decode all the genes in the human body focused attention on the role of genes in many diseases. A monumental study of 15,000 people with MS, including some identical twins who were reared miles apart in different families, clearly demonstrated that there is more »
|
||